Buy Minerva Neurosciences Stock | NERV Stock Price & Latest News | Public
NERV

Minerva Neurosciences

$0.00 (0.00%)Today
    Small Market Cap

    About NERV

    Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. Its product pipeline includes Roluperidone, Seltorexant, MIN-...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0.73
    0.23
    -0.27
    -0.77
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$0.23

    Actual EPS
    Q3 2020

    Stats

    Market Cap$144,21M
    Volume54,38k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$15.21
    1 Year Low$1.81
    Open$3.47
    High$3.55
    Low$3.37

    Buy any stock with any amount of money.

    Download the App
    Download the app